Literature DB >> 26069524

Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats.

Samy M Eleawa1, Mahmoud Alkhateeb2, Sanjoy Ghosh3, Fahaid Al-Hashem4, Abdullah S Shatoor5, Abdulmohsen Alhejaily6, Mohammad A Khalil6.   

Abstract

AIM: Myocardial infarction (MI) due to sudden occlusion of a major coronary artery leads to a complex series of events that result in left ventricle (LV) impairment eventual heart failure. Therapeutic options are limited to reverse such trends post MI. The aim of this study was to compare the acute cardioprotective effects of the antioxidants, resveratrol (RES) and coenzyme Q10 (CoQ10), either individually or in combination, on infracts size, LV hemodynamics, inflammation and oxidative stress markers in rats with experimentally induced MI.
METHODS: Male Wistar rats were randomly divided into six groups: control without surgery, sham without occlusion, MI without antioxidants, RES pre-treated then MI (20 mg/kg, orally), CoQ10 then MI (20 mg/kg, intramuscular.), and combined RES and CoQ10 then MI with (each group n = 10). Pretreatment commenced 7 days prior to the permanent occlusion of the left anterior descending (LAD) coronary artery. Infarct area, hemodynamics, inflammation and oxidative stress markers were assessed 24 hours post-MI.
RESULTS: Compared to RES alone, CoQ10 pre-administration either by itself or in combination with RES, significantly reduced LV infarct area (57%), and normalized LV hemodynamic parameters like LVEDP (100%), LVSP (95.4%), LV +dp/dt and -dp/dt (102 and 73.1%, respectively). CoQ10 also decreased serum levels of brain natriuretic peptide (70%), and various circulating inflammatory markers like TNF-α (83.2%) and IL-6 (83.2%). Regarding oxidative stress, TBARS scores were lowered with a concurrent increase in both superoxide dismutase and glutathione peroxidase activities with CoQ10 alone or in combination with RES.
CONCLUSION: Coenzyme Q10 protects against the acute sequelae of myocardial infarction. It profoundly reduced infarct area, inflammation and oxidative stress while normalizing LV hemodynamics post MI.

Entities:  

Keywords:  Myocardial infarction; apoptosis; coenzyme Q10; hemodynamics; oxidative stress; resveratrol

Year:  2015        PMID: 26069524      PMCID: PMC4446384     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  38 in total

1.  Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease.

Authors:  J McMurray; J McLay; M Chopra; A Bridges; J J Belch
Journal:  Am J Cardiol       Date:  1990-05-15       Impact factor: 2.778

Review 2.  Role of cytokines in heart failure.

Authors:  A Blum; H Miller
Journal:  Am Heart J       Date:  1998-02       Impact factor: 4.749

3.  Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart.

Authors:  Samarjit Das; Vijay K T Alagappan; Debasis Bagchi; Hari S Sharma; Nilanjana Maulik; Dipak K Das
Journal:  Vascul Pharmacol       Date:  2005 Apr-May       Impact factor: 5.773

4.  Coenzyme Q10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect.

Authors:  H Yokoyama; D M Lingle; J A Crestanello; J Kamelgard; B R Kott; R Momeni; J Millili; S A Mortensen; G J Whitman
Journal:  Surgery       Date:  1996-08       Impact factor: 3.982

5.  Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats.

Authors:  Alexander Deten; Hans Christian Volz; Wilfried Briest; Heinz-Gerd Zimmer
Journal:  Cardiovasc Res       Date:  2002-08-01       Impact factor: 10.787

6.  Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats.

Authors:  Jeng-Feng Lin; Su-Man Lin; Chun-Lien Chih; Mao-Wei Nien; Hsin-Hui Su; Bo-Ruei Hu; Shiang-Suo Huang; Shen-Kou Tsai
Journal:  Life Sci       Date:  2008-06-27       Impact factor: 5.037

Review 7.  Stress-activated cytokines and the heart: from adaptation to maladaptation.

Authors:  Douglas L Mann
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

8.  Oxidative stress in patients with unstable angina.

Authors:  J L Dubois-Randé; J Y Artigou; J Y Darmon; R Habbal; C Manuel; I Tayarani; A Castaigne; Y Grosgogeat
Journal:  Eur Heart J       Date:  1994-02       Impact factor: 29.983

9.  Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy.

Authors:  Mehmet Seneş; Ali Riza Erbay; F Meriç Yilmaz; B Ciğdem Topkaya; Oğuzhan Zengi; Mehmet Doğan; Doğan Yücel
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

10.  Coenzyme Q10 prevents accelerated cardiac aging in a rat model of poor maternal nutrition and accelerated postnatal growth.

Authors:  Jane L Tarry-Adkins; Heather L Blackmore; Malgorzata S Martin-Gronert; Denise S Fernandez-Twinn; Josie M McConnell; Iain P Hargreaves; Dino A Giussani; Susan E Ozanne
Journal:  Mol Metab       Date:  2013-09-27       Impact factor: 7.422

View more
  5 in total

1.  Role of Coenzyme Q10 in Prophylaxis of Myocardial Infarction.

Authors:  Iftikhar Ali Shah; Mubeen Memon; Sheeba Ansari; Ratan Kumar; Sultan A Chandio; Shahid H Mirani; Amber Rizwan
Journal:  Cureus       Date:  2021-02-04

2.  Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats.

Authors:  Amr M Abbas
Journal:  J Physiol Biochem       Date:  2016-05-19       Impact factor: 4.158

3.  High plasma coenzyme Q10 concentration is correlated with good left ventricular performance after primary angioplasty in patients with acute myocardial infarction.

Authors:  Ching-Hui Huang; Chen-Ling Kuo; Ching-Shan Huang; Wan-Min Tseng; Ie Bin Lian; Chia-Chu Chang; Chin-San Liu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

4.  Cardioprotective Effect of Coenzyme Q10 on Apoptotic Myocardial Cell Death by Regulation of Bcl-2 Gene Expression.

Authors:  Najam Ali Khan; M Abid; Aftab Ahmad; Mohammed F Abuzinadah; Mohammed Basheikh; Kamal Kishore
Journal:  J Pharmacol Pharmacother       Date:  2017 Jul-Sep

5.  Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy.

Authors:  Ewa Romuk; Wojciech Jacheć; Ewa Kozielska-Nowalany; Ewa Birkner; Aleksandra Zemła-Woszek; Celina Wojciechowska
Journal:  Cell Stress Chaperones       Date:  2019-05-01       Impact factor: 3.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.